Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Building new insights in plant gametogenesis from an evolutionary perspective.

Hisanaga T, Yamaoka S, Kawashima T, Higo A, Nakajima K, Araki T, Kohchi T, Berger F.

Nat Plants. 2019 Jul;5(7):663-669. doi: 10.1038/s41477-019-0466-0. Epub 2019 Jul 8. Review.

PMID:
31285561
2.

Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy.

Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.

PLoS One. 2019 Jun 13;14(6):e0218136. doi: 10.1371/journal.pone.0218136. eCollection 2019.

3.

Evaluation of the Effects of Cultured Bone Marrow Mesenchymal Stem Cell Infusion on Hepatocarcinogenesis in Hepatocarcinogenic Mice With Liver Cirrhosis.

Matsuura K, Takami T, Maeda M, Hisanaga T, Fujisawa K, Saeki I, Matsumoto T, Hidaka I, Yamamoto N, Sakaida I.

Transplant Proc. 2019 Apr;51(3):925-935. doi: 10.1016/j.transproceed.2019.03.011.

PMID:
30979485
4.

Clinical Guidelines for Management of Gastrointestinal Symptoms in Cancer Patients: The Japanese Society of Palliative Medicine Recommendations.

Hisanaga T, Shinjo T, Imai K, Katayama K, Kaneishi K, Honma H, Takagaki N, Osaka I, Matsuo N, Kohara H, Yamaguchi T, Nakajima N.

J Palliat Med. 2019 Aug;22(8):986-997. doi: 10.1089/jpm.2018.0595. Epub 2019 Apr 2.

PMID:
30939064
5.

Development of a Consensus Syllabus of Palliative Medicine for Physicians in Japan Using a Modified Delphi Method.

Sakashita A, Shutoh M, Sekine R, Hisanaga T, Yamamoto R.

Indian J Palliat Care. 2019 Jan-Mar;25(1):30-40. doi: 10.4103/IJPC.IJPC_122_18.

6.

A cis-acting bidirectional transcription switch controls sexual dimorphism in the liverwort.

Hisanaga T, Okahashi K, Yamaoka S, Kajiwara T, Nishihama R, Shimamura M, Yamato KT, Bowman JL, Kohchi T, Nakajima K.

EMBO J. 2019 Mar 15;38(6). pii: e100240. doi: 10.15252/embj.2018100240. Epub 2019 Jan 4.

7.

No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma.

Saeki I, Yamasaki T, Maeda M, Kawano R, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.

Liver Cancer. 2018 Oct;7(4):359-371. doi: 10.1159/000487858. Epub 2018 Apr 6.

8.

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy.

Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Fujisawa K, Matsumoto T, Hidaka I, Marumoto Y, Ishikawa T, Yamamoto N, Suehiro Y, Takami T, Sakaida I.

World J Hepatol. 2018 Sep 27;10(9):571-584. doi: 10.4254/wjh.v10.i9.571. Review.

9.

Efficacy of immediate-release oxycodone for dyspnoea in cancer patient: cancer dyspnoea relief (CDR) trial.

Yamaguchi T, Matsuda Y, Matsuoka H, Hisanaga T, Osaka I, Watanabe H, Maeda I, Imai K, Tsuneto S, Wagatsuma Y, Kizawa Y.

Jpn J Clin Oncol. 2018 Dec 1;48(12):1070-1075. doi: 10.1093/jjco/hyy139.

PMID:
30260399
10.

Plant-inspired pipettes.

Nakamura K, Hisanaga T, Fujimoto K, Nakajima K, Wada H.

J R Soc Interface. 2018 Mar;15(140). pii: 20170868. doi: 10.1098/rsif.2017.0868.

11.

Enantioselective Synthesis of Nelfinavir via Asymmetric Bromocyclization of Bisallylic Amide.

Nagao Y, Hisanaga T, Utsumi T, Egami H, Kawato Y, Hamashima Y.

J Org Chem. 2018 Jul 6;83(13):7290-7295. doi: 10.1021/acs.joc.8b00039. Epub 2018 Mar 1.

PMID:
29480721
12.

Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.

Nishi M, Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.

Hepatol Res. 2018 Mar;48(4):329-332. doi: 10.1111/hepr.12995. Epub 2017 Nov 22.

PMID:
29098752
13.

Desymmetrization of Bisallylic Amides through Catalytic Enantioselective Bromocyclization with BINAP Monoxide.

Nagao Y, Hisanaga T, Egami H, Kawato Y, Hamashima Y.

Chemistry. 2017 Nov 27;23(66):16758-16762. doi: 10.1002/chem.201704847. Epub 2017 Nov 6.

PMID:
29044749
14.

Evaluation of the "assessment for continuous treatment with hepatic arterial infusion chemotherapy" scoring system in patients with advanced hepatocellular carcinoma.

Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.

Hepatol Res. 2018 Feb;48(3):E87-E97. doi: 10.1111/hepr.12932. Epub 2017 Aug 7.

PMID:
28656680
15.

Characterization of Colombian serotype 1 avian paramyxoviruses, 2008-2010.

Berhane Y, Hisanaga T, Xu W, Mosos Campos NA, Kehler H, Calderón Parra CP, Pasick J.

Virus Genes. 2017 Aug;53(4):584-592. doi: 10.1007/s11262-017-1461-z. Epub 2017 Apr 27.

PMID:
28451944
16.

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.

Iwamoto T, Maeda M, Hisanaga T, Saeki I, Fujisawa K, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.

Intern Med. 2016;55(20):2911-2916. Epub 2016 Oct 15.

17.

Adding items that assess changes in activities of daily living does not improve the predictive accuracy of the Palliative Prognostic Index.

Hamano J, Tokuda Y, Kawagoe S, Shinjo T, Shirayama H, Ozawa T, Shishido H, Otomo S, Nagayama J, Baba M, Tei Y, Hiramoto S, Suga A, Hisanaga T, Ishihara T, Iwashita T, Kaneishi K, Kuriyama T, Maeda T, Morita T.

Palliat Med. 2017 Mar;31(3):258-266. doi: 10.1177/0269216316650788. Epub 2016 Jul 19.

PMID:
27412258
18.

An Evolutionarily Conserved Plant RKD Factor Controls Germ Cell Differentiation.

Koi S, Hisanaga T, Sato K, Shimamura M, Yamato KT, Ishizaki K, Kohchi T, Nakajima K.

Curr Biol. 2016 Jul 11;26(13):1775-1781. doi: 10.1016/j.cub.2016.05.013. Epub 2016 Jun 23.

19.

Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter?

Hamano J, Yamaguchi T, Maeda I, Suga A, Hisanaga T, Ishihara T, Iwashita T, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Morita T.

Cancer. 2016 May 1;122(9):1453-60. doi: 10.1002/cncr.29844. Epub 2016 Mar 28.

20.

Pathobiological Characterization of a Novel Reassortant Highly Pathogenic H5N1 Virus Isolated in British Columbia, Canada, 2015.

Berhane Y, Kobasa D, Embury-Hyatt C, Pickering B, Babiuk S, Joseph T, Bowes V, Suderman M, Leung A, Cottam-Birt C, Hisanaga T, Pasick J.

Sci Rep. 2016 Mar 18;6:23380. doi: 10.1038/srep23380.

21.

Hemagglutinin-Neuraminidase Balance Influences the Virulence Phenotype of a Recombinant H5N3 Influenza A Virus Possessing a Polybasic HA0 Cleavage Site.

Diederich S, Berhane Y, Embury-Hyatt C, Hisanaga T, Handel K, Cottam-Birt C, Ranadheera C, Kobasa D, Pasick J.

J Virol. 2015 Nov;89(21):10724-34. doi: 10.1128/JVI.01238-15. Epub 2015 Aug 5.

22.

Reassortant highly pathogenic influenza A H5N2 virus containing gene segments related to Eurasian H5N8 in British Columbia, Canada, 2014.

Pasick J, Berhane Y, Joseph T, Bowes V, Hisanaga T, Handel K, Alexandersen S.

Sci Rep. 2015 Mar 25;5:9484. doi: 10.1038/srep09484.

23.

Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.

Miura T, Matsumoto Y, Hama T, Amano K, Tei Y, Kikuchi A, Suga A, Hisanaga T, Ishihara T, Abe M, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Morita T, Kinoshita H.

Support Care Cancer. 2015 Nov;23(11):3149-56. doi: 10.1007/s00520-015-2693-x. Epub 2015 Mar 17.

PMID:
25777319
24.

Compensation: a key to clarifying the organ-level regulation of lateral organ size in plants.

Hisanaga T, Kawade K, Tsukaya H.

J Exp Bot. 2015 Feb;66(4):1055-63. doi: 10.1093/jxb/erv028. Epub 2015 Jan 29. Review.

PMID:
25635111
25.

Independent validation of the modified prognosis palliative care study predictor models in three palliative care settings.

Baba M, Maeda I, Morita T, Hisanaga T, Ishihara T, Iwashita T, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Ono S, Ozawa T, Yamamoto R, Tsuneto S.

J Pain Symptom Manage. 2015 May;49(5):853-60. doi: 10.1016/j.jpainsymman.2014.10.010. Epub 2014 Dec 12.

PMID:
25499420
26.

Small RNAs as positional signal for pattern formation.

Hisanaga T, Miyashima S, Nakajima K.

Curr Opin Plant Biol. 2014 Oct;21:37-42. doi: 10.1016/j.pbi.2014.06.005. Epub 2014 Jul 6. Review.

PMID:
25005923
27.

Characterization of a low pathogenic avian influenza H5N2 virus isolated from a turkey breeder flock in Manitoba, Canada.

Berhane Y, Joseph T, Kehler H, Hisanaga T, Embury-Hyatt C, Diederich S, McGreevy KH, Handel K, Cottam-Birt C, Pasick J.

Avian Dis. 2014 Mar;58(1):1-7.

PMID:
24758106
28.

Pneumocystis pneumonia in patients treated with long-term steroid therapy for symptom palliation: a neglected infection in palliative care.

Yamaguchi T, Nagai Y, Morita T, Kiuchi D, Matsumoto M, Hisahara K, Hisanaga T.

Am J Hosp Palliat Care. 2014 Dec;31(8):857-61. doi: 10.1177/1049909113504238. Epub 2013 Sep 30.

PMID:
24081789
29.

The ATM-dependent DNA damage response acts as an upstream trigger for compensation in the fas1 mutation during Arabidopsis leaf development.

Hisanaga T, Ferjani A, Horiguchi G, Ishikawa N, Fujikura U, Kubo M, Demura T, Fukuda H, Ishida T, Sugimoto K, Tsukaya H.

Plant Physiol. 2013 Jun;162(2):831-41. doi: 10.1104/pp.113.216796. Epub 2013 Apr 24.

30.

The first reported case of rabbit hemorrhagic disease in Canada.

Embury-Hyatt C, Postey R, Hisanaga T, Burton L, Hooper-McGrevy K, McIntyre L, Millar K, Pasick J.

Can Vet J. 2012 Sep;53(9):998-1002.

31.

Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.

Iwamoto T, Terai S, Hisanaga T, Takami T, Yamamoto N, Watanabe S, Sakaida I.

Cell Tissue Res. 2013 Mar;351(3):487-95. doi: 10.1007/s00441-012-1528-z. Epub 2012 Nov 27.

PMID:
23183782
32.

Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells.

Shimojo Y, Akimoto M, Hisanaga T, Tanaka T, Tajima Y, Honma Y, Takenaga K.

Clin Exp Metastasis. 2013 Feb;30(2):143-54. doi: 10.1007/s10585-012-9519-8. Epub 2012 Jul 26.

PMID:
22833345
33.

Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.

Terai S, Tanimoto H, Maeda M, Zaitsu J, Hisanaga T, Iwamoto T, Fujisawa K, Mizunaga Y, Matsumoto T, Urata Y, Marumoto Y, Hidaka I, Ishikawa T, Yokoyama Y, Aoyama K, Tsuchiya M, Takami T, Omori K, Yamamoto N, Segawa M, Uchida K, Yamasaki T, Okita K, Sakaida I.

J Gastroenterol. 2012 May;47(5):491-7. doi: 10.1007/s00535-012-0580-5. Epub 2012 Apr 5. Review.

PMID:
22488349
34.

Molecular and antigenic characterization of reassortant H3N2 viruses from turkeys with a unique constellation of pandemic H1N1 internal genes.

Berhane Y, Kehler H, Handel K, Hisanaga T, Xu W, Ojkic D, Pasick J.

PLoS One. 2012;7(3):e32858. doi: 10.1371/journal.pone.0032858. Epub 2012 Mar 21.

35.

TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion.

Hisanaga T, Terai S, Iwamoto T, Takami T, Yamamoto N, Murata T, Matsuyama T, Nishina H, Sakaida I.

Cell Tissue Res. 2011 Oct;346(1):79-88. doi: 10.1007/s00441-011-1236-0. Epub 2011 Oct 11.

36.

Characterization of H1N1 swine influenza viruses circulating in Canadian pigs in 2009.

Nfon CK, Berhane Y, Hisanaga T, Zhang S, Handel K, Kehler H, Labrecque O, Lewis NS, Vincent AL, Copps J, Alexandersen S, Pasick J.

J Virol. 2011 Sep;85(17):8667-79. doi: 10.1128/JVI.00801-11. Epub 2011 Jun 22.

37.

Molecular characterization of pandemic H1N1 influenza viruses isolated from turkeys and pathogenicity of a human pH1N1 isolate in turkeys.

Berhane Y, Ojkic D, Neufeld J, Leith M, Hisanaga T, Kehler H, Ferencz A, Wojcinski H, Cottam-Birt C, Suderman M, Handel K, Alexandersen S, Pasick J.

Avian Dis. 2010 Dec;54(4):1275-85.

PMID:
21313850
38.

Temporary improvement in activities of daily living after steroid therapy for the treatment of anti-Hu antibody-associated syndrome in a patient with advanced prostate cancer.

Yamaguchi T, Kamiya K, Izumi N, Hisanaga T, Higashi K, Shima Y.

J Pain Symptom Manage. 2011 Feb;41(2):e6-8. doi: 10.1016/j.jpainsymman.2010.10.254. Epub 2011 Jan 12. No abstract available.

PMID:
21227635
39.

Phylogenetic analysis of classical swine fever virus isolates from Peru.

Araínga M, Hisanaga T, Hills K, Handel K, Rivera H, Pasick J.

Transbound Emerg Dis. 2010 Aug 1;57(4):262-70. doi: 10.1111/j.1865-1682.2010.01144.x. Epub 2010 Jun 10.

PMID:
20545910
40.

Studying possible cross-protection of Canada geese preexposed to North American low pathogenicity avian influenza virus strains (H3N8, H4N6, and H5N2) against an H5N1 highly pathogenic avian influenza challenge.

Berhane Y, Leith M, Embury-Hyatt C, Neufeld J, Babiuk S, Hisanaga T, Kehler H, Hooper-McGrevy K, Pasick J.

Avian Dis. 2010 Mar;54(1 Suppl):548-54.

PMID:
20521692
41.

Survey of influenza A viruses circulating in wild birds in Canada 2005 to 2007.

Pasick J, Berhane Y, Kehler H, Hisanaga T, Handel K, Robinson J, Ojkic D, Kibenge F, Fortin M, King R, Hamel A, Spiro D, Parmley J, Soos C, Jenkins E, Breault A, Caswell D, Davies C, Rodrigue J, McAloney K, Leighton F.

Avian Dis. 2010 Mar;54(1 Suppl):440-5.

PMID:
20521675
42.

Diagnostic test results and pathology associated with the 2007 Canadian H7N3 highly pathogenic avian influenza outbreak.

Pasick J, Berhane Y, Hisanaga T, Kehler H, Hooper-McGrevy K, Handel K, Neufeld J, Argue C, Leighton F.

Avian Dis. 2010 Mar;54(1 Suppl):213-9.

PMID:
20521634
43.

Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.

Hisanaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, Kizawa Y, Maeno T, Shima Y, Hyodo I.

Jpn J Clin Oncol. 2010 Aug;40(8):739-45. doi: 10.1093/jjco/hyq048. Epub 2010 Apr 21.

PMID:
20410056
44.

Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd.

Weingartl HM, Berhane Y, Hisanaga T, Neufeld J, Kehler H, Emburry-Hyatt C, Hooper-McGreevy K, Kasloff S, Dalman B, Bystrom J, Alexandersen S, Li Y, Pasick J.

J Virol. 2010 Mar;84(5):2245-56. doi: 10.1128/JVI.02118-09. Epub 2009 Dec 16.

45.

Highly pathogenic avian influenza virus A (H7N3) in domestic poultry, Saskatchewan, Canada, 2007.

Berhane Y, Hisanaga T, Kehler H, Neufeld J, Manning L, Argue C, Handel K, Hooper-McGrevy K, Jonas M, Robinson J, Webster RG, Pasick J.

Emerg Infect Dis. 2009 Sep;15(9):1492-5. doi: 10.3201/eid1509.080231.

46.
47.

Perceptions of specialized inpatient palliative care: a population-based survey in Japan.

Sanjo M, Miyashita M, Morita T, Hirai K, Kawa M, Ashiya T, Ishihara T, Miyoshi I, Matsubara T, Nakaho T, Nakashima N, Onishi H, Ozawa T, Suenaga K, Tajima T, Hisanaga T, Uchitomi Y.

J Pain Symptom Manage. 2008 Mar;35(3):275-82. doi: 10.1016/j.jpainsymman.2007.04.021. Epub 2008 Jan 28.

PMID:
18222630
48.

Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).

Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.

J Antimicrob Chemother. 2007 Oct;60(4):733-40. Epub 2007 Aug 2.

PMID:
17673477
49.

[Severe Graves' ophthalmopathy accompanied by myasthenia gravis].

Maeda K, Kume S, Nishio Y, Maeda S, Nishida Y, Suzuki M, Nakaguchi T, Kawabata T, Hashimoto O, Hisanaga T, Kashiwagi A, Yasuda H.

Rinsho Shinkeigaku. 2006 Apr;46(4):266-9. Japanese.

PMID:
16768093
50.

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA; NAUTICA Group, Hoban DJ.

Int J Antimicrob Agents. 2006 Jun;27(6):468-75. Epub 2006 May 18.

PMID:
16713191

Supplemental Content

Loading ...
Support Center